Evan G. Dick - 19 Oct 2021 Form 3/A - Amendment Insider Report for Context Therapeutics Inc. (CNTX)

Role: SVP of R&D
Signature: /s/ Alex Levit, Attorney-in-Fact
Issuer symbol: CNTX
Transactions as of: 19 Oct 2021
Net transactions value: $0
Form type: 3/A - Amendment
Filing time: 17 Dec 2021, 15:10:48 UTC
Date Of Original Report: 19 Oct 2021
Next filing: 17 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CNTX	Common Stock						56,373	19 Oct 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 33,397 restricted stock units which fully vest on January 31, 2023.

Remarks:

The numbers in Table 1 and the footnote thereto (including the date in the footnote) in this Form are to correct the respective numbers filed in the original Form 3 on October 19, 2021.